These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6979308

  • 21. Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production.
    Aldridge KE, Sanders CV, Lewis AC, Marier RL.
    J Med Microbiol; 1983 Feb; 16(1):75-82. PubMed ID: 6218305
    [Abstract] [Full Text] [Related]

  • 22. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T, Yokota E, Nakane T, Inoue E, Mitsuhashi S.
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [Abstract] [Full Text] [Related]

  • 23. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW, Weeks LS, Aldridge KE.
    Diagn Microbiol Infect Dis; 1992 Sep; 15(4):321-30. PubMed ID: 1611847
    [Abstract] [Full Text] [Related]

  • 24. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
    Neu HC, Chin NX, Labthavikul P.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
    [Abstract] [Full Text] [Related]

  • 25. Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics.
    Dumon L, Adriaens P, Anné J, Eyssen H.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):315-7. PubMed ID: 311619
    [Abstract] [Full Text] [Related]

  • 26. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
    Rotschafer JC, Ostergaard BE.
    Am J Health Syst Pharm; 1995 Mar 15; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
    [Abstract] [Full Text] [Related]

  • 27. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics.
    Melchior NH, Keiding J.
    J Antimicrob Chemother; 1991 Jan 15; 27(1):29-40. PubMed ID: 1646779
    [Abstract] [Full Text] [Related]

  • 28. Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases.
    Livermore DM, Mushtaq S, Warner M, Woodford N.
    J Antimicrob Chemother; 2015 Nov 15; 70(11):3032-41. PubMed ID: 26311835
    [Abstract] [Full Text] [Related]

  • 29. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
    Sakamoto M, Ishikura T, Fukagawa Y.
    J Antibiot (Tokyo); 1984 Nov 15; 37(11):1414-22. PubMed ID: 6334679
    [Abstract] [Full Text] [Related]

  • 30. Azlocillin and mezlocillin: new ureido penicillins.
    Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1978 Jun 15; 13(6):930-8. PubMed ID: 677860
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria].
    Kuga A, Yano H, Okamoto R, Sato Y, Miyata A, Inoue M.
    Jpn J Antibiot; 1999 Sep 15; 52(9):585-94. PubMed ID: 10746193
    [Abstract] [Full Text] [Related]

  • 33. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
    Neu HC, Fu KP.
    Antimicrob Agents Chemother; 1980 Oct 15; 18(4):582-5. PubMed ID: 6255862
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.
    Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1978 Mar 15; 13(3):358-67. PubMed ID: 122519
    [Abstract] [Full Text] [Related]

  • 36. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW, Arslan Khan M, Amiera Syuhada N, Chean Ring L, Ibrahim D, Tan WN.
    Steroids; 2017 Dec 15; 128():68-71. PubMed ID: 29104098
    [Abstract] [Full Text] [Related]

  • 37. Review of the in vitro spectrum of activity of imipenem.
    Jones RN.
    Am J Med; 1985 Jun 07; 78(6A):22-32. PubMed ID: 3890537
    [Abstract] [Full Text] [Related]

  • 38. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Tsuji H, Ohashi Y, Okumura K, Tsuji A, Muto Y, Goto S.
    Chemotherapy; 1982 Jun 07; 28(1):26-39. PubMed ID: 7035089
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.